Stay updated on Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.

Latest updates to the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new Revision: v3.3.3 is shown, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 label were removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.3.2 was added and an older revision v3.2.0 was removed on the Record History page. This reflects internal version control rather than changes to study data or visible content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedRemoved the government funding/operating status notice from the page. The page now presents the study record history without that banner.SummaryDifference0.2%

- Check60 days agoChange DetectedStudy status updated to Terminated due to manufacturer withdrawal of support and lack of enrollment.SummaryDifference0.0%

- Check89 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference6%

- Check96 days agoChange DetectedUpdate indicates a version bump from v3.0.2 to v3.1.0; no other content changes are present.SummaryDifference0.2%

Stay in the know with updates to Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab with IL-15 in Clear-Cell Renal Carcinoma Clinical Trial page.